Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
N-ACETYL MANNOSAMMINE AS THERAPEUTIC AGENT
Document Type and Number:
Japanese Patent JP2016196505
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide compositions and methods for treating kidney and muscle dysfunction.SOLUTION: The invention relates to use of N-acetyl mannosamine represented by formula I or a derivative thereof [R1 and R3-R5 are H, lower alkanoyl, carboxylate, or lower alkyl; R2 is lower alkyl, lower alkanoyl alkyl, and lower alkyl alkanoyloxy].SELECTED DRAWING: Figure 5A

Inventors:
MARJAN HUIZING
WILLIAM A GAHL
IRINI MANOLI
ENRIKO KLOOTWIJK
Application Number:
JP2016159061A
Publication Date:
November 24, 2016
Filing Date:
August 15, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
US GOVERNMENT
International Classes:
A61K31/7008; A61P13/12; A61P21/00; A61P21/04; A61P43/00
Other References:
HUIZING,M. ET AL: "N-acetylmannosamine treatment rescues a mouse model of hereditary inclusion body myopathy", GLYCOBIOLOGY, vol. 16, no. 11, JPN7013000453, 2006, pages 1110 - 1111, XP009108903
NOGUCHI,S. ET AL: "Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation", J BIOL CHEM, vol. 279, no. 12, JPN7013000454, 2004, pages 11402 - 7, XP002504699, DOI: doi:10.1074/jbc.m313171200
HONG,Y. ET AL: "Lec3 Chinese hamster ovary mutants lack UDP-N-acetylglucosamine 2-epimerase activity because of muta", J BIOL CHEM, vol. 278, no. 52, JPN7013000455, 2003, pages 53045 - 54, XP002504700, DOI: doi:10.1074/JBC.M309967200
NEUROLOGY, vol. Vol.60, No.supplement1,, JPN6013005876, 2003, pages 4 - 133
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Kazuya Kawamoto